Skip to content

Telemedicine With Metabolic Syndrome

Risk Reduction in Patients With Metabolic Syndrome Through Telemedicine-led Lifestyle Interventions

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05117580
Acronym
METSZI
Enrollment
130
Registered
2021-11-11
Start date
2021-07-01
Completion date
2022-02-28
Last updated
2021-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Life Style, Metabolic Syndrome

Keywords

Telemedicine

Brief summary

Investigation of the effect of a 3-month telemedicine-led lifestyle intervention on cardiovascular risk factors, functional indicators, in patients with metabolic syndrome.

Detailed description

The patients are using mobile phone-based nutrition diary with heart rate monitoring watch (including activity meter) connected to a mobile phone with bluetooth technology worn on a wrist. These devices, and the weight scale, blood pressure monitor are connected with bluetooth to an IT system, that transmits and displays data from these devices. the patients are using the devices during 3 months, and get instructions about lifestyle.

Interventions

DEVICEtelemedicine lifestyle guidance

Telemedicine lifestyle advices are given during 3 months, based on telemonitoring system data.

Sponsors

Szeged University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 years and 75 years * Presence of at least three of the following five risk factors (Metabolic Syndrome ATP III Criteria): 1. waist width above 102 cm in men and 88 cm in women 2. treated diabetes or blood sugar above 5.6 mmol / l 3. treated hypertension or spontaneous blood pressure ≥ 130/85 mmHg 4. fibrate treatment or triglyceride levels above 1.7 mmol / l 5. blood HDL cholesterol levels below 1.03 mmol / l in men and 1.3 mmol / l in women

Exclusion criteria

* Low level of physical activity (less than 30 minutes a day) * IT proficiency at least for basic use of mobile phones (answering / making voice calls). * For women with childbearing potential, by definition, all women who are able to conceive physiologically use dual contraception * Signing an informed consent. * The subject communicates well with the investigator and is able to help understand and adhere to the requirements of the study plan.

Design outcomes

Primary

MeasureTime frameDescription
Change of abdominal circumference3 monthsTo investigate the effect of telemedicine-assisted lifestyle intervention on anthropometric parameters, with particular reference to the reduction of abdominal circumference in patients with metabolic syndrome.

Secondary

MeasureTime frameDescription
Number of participants with treatment-related adverse events as assessed by CTCAE v4.3 monthsThe safety of the device system
Impact of the system to the cardiovascular risk3 monthsIn patients with metabolic syndrome, high cardiovascular risk, the impact of complex lifestyle interventions initiated in different environments and then telemedicine, including lifestyle and physical activity, on the known cardiovascular risk factors and functional indicators

Countries

Hungary

Contacts

Primary ContactIstván Kósa, MD, Ph.D.
office.prevmedicina@med.u-szeged.hu+36 70 320 1192

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026